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Objectives The aim of this study was to compare fully quantitative cardiovascular magnetic resonance (CMR) and positron
emission tomography (PET) myocardial perfusion and myocardial perfusion reserve (MPR) measurements in pa-
tients with coronary artery disease (CAD).
Background Absolute quantification of myocardial perfusion and MPR with PET have proven diagnostic and prognostic roles
in patients with CAD. Quantitative CMR perfusion imaging has been established more recently and has been
validated against PET in normal hearts. However, there are no studies comparing fully quantitative CMR against
PET perfusion imaging in patients with CAD.
Methods Forty-one patients with known or suspected CAD prospectively underwent quantitative 13N-ammonia PET and
CMR perfusion imaging before coronary angiography.
Results The CMR-derived MPR (MPRCMR) correlated well with PET-derived measurements (MPRPET) (r  0.75, p 
0.0001). MPRCMR and MPRPET for the 2 lowest scoring segments in each coronary territory also correlated
strongly (r  0.79, p  0.0001). Absolute CMR perfusion values correlated significantly, but weakly, with PET
values both at rest (r  0.32; p  0.002) and during stress (r  0.37; p  0.0001). Area under the receiver-
operating characteristic curve for MPRPET to detect significant CAD was 0.83 (95% confidence interval: 0.73 to
0.94) and for MPRCMR was 0.83 (95% confidence interval: 0.74 to 0.92). An MPRPET 1.44 predicted significant
CAD with 82% sensitivity and 87% specificity, and MPRCMR 1.45 predicted significant CAD with 82% sensitivity
and 81% specificity.
Conclusions There is good correlation between MPRCMR and MPRPET. For the detection of significant CAD, MPRPET and
MPRCMR seem comparable and very accurate. However, absolute perfusion values from PET and CMR are only
weakly correlated; therefore, although quantitative CMR is clinically useful, further refinements are still
required. (J Am Coll Cardiol 2012;60:1546–55) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.05.052Noninvasive assessment of myocardial perfusion is clinically
important, particularly for the detection and management of
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October 16, 2012:1546–55 Comparison of CMR and PET Perfusion Imagingrelative perfusion. However, this approach relies on the presence
of a normally perfused region of myocardium. Quantification
of perfusion addresses this limitation, and positron emission
tomography (PET) studies have confirmed that it provides
incremental value compared with nonquantitative methods (1).
See page 1556
Positron emission tomography can accurately quantify
perfusion and myocardial perfusion reserve (MPR) and is
currently the noninvasive reference standard. Fully quanti-
tative methods are accurate for the detection of CAD (1)
and can result in improved diagnostic accuracy compared
with relative perfusion analysis (2). Recent studies have also
demonstrated that an abnormal quantitative MPR is an inde-
pendent predictor of an adverse prognosis (3,4). Furthermore,
quantitative data provide unique information about the coro-
nary microcirculation that is not available from nonquantitative
methods (5).
Cardiac magnetic resonance (CMR) has, relatively re-
cently, established itself as an accurate and valuable tool for
perfusion imaging (6). Currently, visual assessment is stan-
dard; however, absolute quantification of perfusion has also
been demonstrated to be feasible and accurate (7–10).
Quantitative CMR methods have been validated against
microspheres in animals (7), coronary sinus flow in patients
(9), and PET in healthy volunteers (11–13). However, to
date, there is a lack of evidence comparing quantitative
CMR with PET in patients with CAD. Patient studies are
clinically more relevant, given the inherent differences be-
tween patients and healthy volunteers. Therefore, the pri-
mary aim of this study was to compare quantitative assess-
ment of myocardial perfusion and MPR with CMR and
PET in a cohort of patients with known or suspected CAD.
Methods
Patient population and study design. Patients with a
history of stable angina and known or suspected CAD
underwent CMR and PET perfusion imaging before
planned x-ray coronary angiography. Exclusion criteria:
acute coronary syndrome 6 weeks, previous coronary
rtery bypass graft, previous ST-segment elevation infarc-
ion, estimated glomerular filtration rate 30 ml/min, or
contraindication to magnetic resonance imaging or adeno-
sine. The local ethics committee approved the study, and
the U.K. Administration of Radioactive Substances Advi-
sory Committee licensed radiation exposure. All patients
gave written informed consent.
Data acquisition. Patients were instructed to abstain from
caffeine and smoking for 24 h before imaging.
CMR imaging. Data were acquired with a 1.5-T scanner
(Achieva, Philips, Best, the Netherlands) and a 32-channel
coil. Examinations included high-resolution perfusion and
functional and scar imaging. Perfusion imaging consisted of s3 short-axis slices acquired every
heartbeat covering 16 of the stan-
dard myocardial segments (14)
(apex excluded). Stress imaging
preceded rest by 14  2 min
(range 10 to 19 min). Imaging
parameters: k-t balanced turbo
radient echo sequence, shortest
cho time (range 1.35 to 1.54 ms),
hortest repetition time (range
.64 to 3.12 ms), 50° flip angle; 90°
repulse, 100-ms prepulse delay,
nd typical acquired resolution
.7  1.9  10 mm. For stress
imaging, 140 g/kg/min of aden-
osine was administered intrave-
nously for 4 min. Imaging com-
menced 3 min into the infusion and
continued for 1 min. A dual bolus
(equal volumes of 0.01 mmol/kg
followed by 0.1 mmol/kg after a
20-s pause) of contrast agent (gad-
obutrol/Gadovist, Berlin-Wedding,
Schering, Germany) was injected at
4 ml/s by a power injector for per-
fusion imaging (15).
PET imaging. This was performed with a GE Discovery
VCT PET-CT scanner (GE Healthcare, Waukesha, Wis-
consin) after administration of 13N ammonia, with 47
ransaxial slices reconstructed over an axial field of view of
5 cm. Acquired resolution was 4.8  4.8  4.9 mm.
omputed tomography (CT) scout data determined patient
osition, and a low-dose CT was used for attenuation
orrection. Acquisition consisted of dynamic scans from 0 to
min (12  10 s, 6  20 s, and 2  60 s) and then a single
static scan frame for 20 min. For the rest study, a total of
550 MBq of 13N-ammonia was injected intravenously.
Stress imaging was performed approximately 50 min later.
Adenosine (140 g/kg/min) was administered intravenously
or 6 min, with a second equivalent dose of 13N-ammonia
dministered 2 min into the infusion. Patients remained on
he scanner table throughout the entire study; however,
ttenuation correction was repeated for the stress study.
-ray coronary angiography. This was performed accord-
ng to the standard Judkin’s technique. Multiple projections
f the coronary arteries were acquired, including at least 2
rthogonal views to assess stenosis severity.
isual analysis. Studies were analyzed by 2 independent
xperts blinded to all other data. The PET scans were
lassified as positive for CAD in the presence of a stress-
nduced perfusion defect involving 2 myocardial segments
nd CMR scans in the presence of a stress-induced perfu-
ion defect, which was transmural or involved 2 myocar-
ial segments. In the case of disagreement between the
bservers, the images were reviewed together, and a con-
Abbreviations
and Acronyms
AUC  area under the
receiver-operating
characteristic curve
CAD  coronary artery
disease
CI  confidence interval
CMR  cardiovascular
magnetic resonance
CT  computed
tomography
CV  coefficient of
variation
MPR  myocardial
perfusion reserve
PCI  percutaneous
coronary intervention
PET  positron emission
tomography
QCA  quantitative
coronary angiography
ROC  receiver-operating
characteristicensus was reached.
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Comparison of CMR and PET Perfusion Imaging October 16, 2012:1546–55Quantitative analysis. Quantitative analysis was per-
formed by 1 of the experts. Perfusion was quantified in 16
standard American Heart Association segments. Segments
were defined separately for the PET and CMR images with
the right ventricular insertion points for reference. Segment
17 was excluded. Myocardial border detection was automated
and manually corrected where required. Segments unsuitable
for analysis due to artifact or poor image quality were excluded.
The CMR segments demonstrating late gadolinium enhance-
ment and PET data from patients with 10-mm movement
between the CT and PET were considered unreliable and also
excluded. Coronary territories were excluded if all relevant
segments were unsuitable for analysis.
PET. Original dynamic raw PET scans were used to
calculate arterial input function and mean segmental perfu-
sion calculated over the linear portion of the curve from 70
to 210 s, with Quick Cardiac (Hermes Medical Solutions,
Stockholm, Sweden) in conjunction with software devel-
oped at our institution based on the Patlak method as
previously described and validated (16).
CMR. Mean segmental perfusion values were obtained
with dedicated ViewForum software (Philips) and the
previously validated Fermi deconvolution method (7).
PET AND CMR. Each segment was assigned to the appro-
riate perfusion territory (14), with segment 15 assigned to
he dominant coronary artery (defined by the observer
nalyzing the angiogram). Myocardial perfusion reserve was
efined as stress perfusion divided by rest perfusion and was
alculated for each segment and territory. For CAD detec-
ion, mean MPR of the 2 lowest scoring segments for each
erfusion territory (MPR2) was used for further analysis as
escribed previously (17).
X-RAY ANGIOGRAPHY. All coronary arteries 2 mm in
iameter were assessed by an independent cardiologist
linded to all other data. Stenoses 30% and 95% on
visual analysis were judged to be nonflow-limiting or flow-
limiting, respectively, without further assessment. Quanti-
tative coronary angiography (QCA) was performed for all
arteries with a visual stenosis severity of 30% to 95% with a
dedicated software program (Medcon UK, Edgware,
Middlesex, United Kingdom). Mean diameter stenosis from
2 orthogonal views was recorded, and 70% was regarded
as significant. Coronary territories subtended by a coronary
artery with 70% stenosis were classified as stenotic terri-
tories, and all others were classified as remote.
Statistical analysis. The IBM SPSS Statistics (version
19.0, SPSS, Chicago, Illinois) and Medcalc software (Med-
calc, Mariakerke, Belgium) were used. Data are presented as
mean  SD, except where stated. Shapiro-Wilk analysis
defined when nonparametric tests were required. Agree-
ment and correlations between PET and CMR were deter-
mined with Bland-Altman plots and Spearman’s test of
correlation with a 2-tailed test of significance, respectively.Analyses were performed on a per-observation basis. Be-
cause 3 perfusion territories were analyzed/patient, analyses
were repeated within each territory to ensure that any strong
correlations did not simply reflect high within-subject cor-
relations. Intraobserver and interobserver reproducibility
was determined by a coefficient of variation (CV): SD of the
differences divided by the mean. Paired and independent t
tests were used for comparison of paired and unpaired mean
data, respectively. Receiver-operating characteristic (ROC)
analysis determined the accuracy of visual analysis, MPR2, and
stress perfusion values from PET and CMR for predicting a
corresponding coronary artery stenosis of 70% on QCA.
ptimal cutoffs were determined by the maximum Youden
ndex. Logistic regression models were used to calculate the
rea under the receiver-operating characteristic curve (AUC)
hen information from both CMR and PET were combined,
nd this was compared with the ROC curves when CMR or
ET was used alone. Sensitivity and specificity were compared
ith McNemar’s test. Significance was determined at 0.05.
Baseline Characteristics of Study ParticipantsTable 1 Baseline Characteristics of Study Participants
Age (yrs) 63 9
Male 32 (78%)
BMI (kg/m2) 29 5
LVEF (%) 63 12
Angina (CCS)
Class 1 11 (27%)
Class 2 22 (54%)
Class 3 8 (20%)
Diabetes 13 (32%)
Hypertension 30 (73%)
Smoking
Current 5 (12%)
Previous 21 (51%)
Family history CAD 19 (46%)
Cerebrovascular disease 4 (10%)
Previous PCI 13 (32%)
Previous myocardial infarct 5 (12%)
Medications
Aspirin 33 (80%)
Clopidogrel 18 (44%)
Statin 35 (85%)
ACE inhibitor 22 (54%)
Angiotensin receptor blocker 6 (15%)
Beta-blocker 21 (51%)
Calcium channel blocker 13 (32%)
Nitrate 7 (17%)
Coronary disease 70%
Left anterior descending 7 (17%)
Circumflex 12 (29%)
Right coronary artery 13 (32%)
Values aremean SD or n (%). Percentages have been rounded to nearest 1% and thereforemight
not total 100%.
ACE angiotensin-converting enzyme; BMI body mass index; CAD coronary artery disease;
CCS  Canadian Cardiovascular Society; LVEF  left ventricular ejection fraction; PCI  percuta-
neous coronary intervention.
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Study population. Forty-one patients were recruited.
Table 1 shows baseline characteristics. The study protocol
was completed in 38 patients (exclusions: 1 atrioventricular
block, 1 withdrawal of consent, 1 claustrophobia), and
further analysis relates to these patients. Hemodynamic
status during imaging is shown in Table 2. Resting heart
rate was significantly higher during CMR studies (66 vs. 63
beats/min, respectively). There were no significant differ-
ences between rate pressure product, systolic blood pressure,
or stress heart rate during CMR and PET studies.
The interval between PET and CMR scans was 3 6 days;
26 (63%) patients underwent both on the same day. The
coronary angiogram was 17 19 days and 17 21 days after
the CMR and PET, respectively. Twenty-five patients (61%)
had1 stenosis of70% diameter. Nineteen had single-vessel
disease, 5 had 2-vessel disease, and 1 had 3-vessel disease. Left
ventricular ejection fraction (CMR) was 63  12%.
Myocardial perfusion. All perfusion studies were suitable
for visual analysis. Quantitative data were available for 89%,
84%, and 73% of territories with CMR, PET, and both
modalities, respectively. Results are summarized in Table 3.
In patients with CAD stress perfusion, MPR and MPR2
were significantly lower in stenotic territories compared
with remote territories with both PET and CMR. Con-
versely, rest perfusion was not significantly different.
Summary of Hemodynamic Data for All ParticipaTable 2 Su mary of Hemodynamic Data for
Rest
PET CMR p Va
HR 63 10 66 11 0.0
SBP 138 18 137 17 0.7
RPP 8,734 336 9,122 329 0.1
Values are mean  SD.
CMR cardiovascular magnetic resonance; HR heart rate; PET
blood pressure.
Quantitative Perfusion Values in Patients With aTable 3 Quantitative Perfusion Values in Pa
Stenotic Territory
Stress perfusion (ml/min/g)
PET 1.24 0.49
CMR 1.54 0.34
Rest perfusion (ml/min/g)
PET 0.77 0.24
CMR 1.03 0.30
MPR
PET 1.57 0.31
CMR 1.55 0.36
Mean MPR of 2 lowest segments
PET 1.36 0.32
CMR 1.31 0.30
Values are mean  SD. A stenotic territory is subtended by a coronary
coronary arteries with 70% stenosis. *Significance of the difference
between the values in patients without coronary artery disease (CAD) and rem
CMR  cardiovascular magnetic resonance; MPR  myocardial perfusionThe MPR2PET was 1.36  0.32 and 1.74  0.32 in
tenotic and remote territories, respectively (p  0.0001).
he MPR2CMR values were 1.31  0.30 and 1.70  0.42
(p  0.0001). In patients without significant CAD,
MPR2PET was 1.92  0.39, and MPR2CMR was 1.93 
0.53 (p  0.14 and p  0.16, respectively, compared with
emote territories in patients with CAD).
greement between CMR and PET. There was good
orrelation between MPRCMR and MPRPET (r 0.75; p
0.0001) (Fig. 1A) and between MPR2CMR and MPR2PET
(r  0.79; p  0.0001) (Fig. 1B). A Bland-Altman plot
demonstrates good agreement between MPRCMR and
PRPET (Fig. 2). Absolute CMR perfusion values corre-
lated significantly, but weakly, with PET values both at rest
(r  0.32; p  0.002) and during stress (r  0.37; p 
0.0001) (Fig. 3). Results were similar when analyses were
repeated within each territory. The MPRCMR correlated
well with MPRPET in the left anterior descending coronary
artery (r  0.79; p  0.0001), circumflex (r  0.64; p 
0.0001), and right coronary artery territories (r  0.77; p 
0.0001). Bland-Altman limits of agreement for MPRCMR
and MPRPET also remained similar in the left anterior
escending coronary artery (0.71 to 0.58), circumflex (0.7
o 0.8), and right coronary artery territories (0.62 to 0.48).
eproducibility. Intraobserver CV for PET stress perfusion,
est perfusion, and MPR were 9%, 12%, and 15%, respectively.
uring Imaging Studiesarticipants During Imaging Studies
Stress
PET CMR p Value
84 15 86 15 0.14
128 21 132 19 0.164
10,781 479 11,344 445 0.08
n emission tomography; RPP rate pressure product; SBP systolic
ithout Significant CADs With and Without Significant CAD
D No CAD
ote Territory p Value* All Territories p Value†
56 0.66 0.0001 1.72 0.66 0.49
94 0.59 0.001 2.03 0.63 0.68
81 0.25 0.08 0.85 0.26 0.71
06 0.33 0.28 0.98 0.29 0.47
87 0.36 0.0001 2.06 0.44 0.20
90 0.48 0.001 2.20 0.56 0.13
74 0.32 0.0001 1.92 0.39 0.14
70 0.42 0.0001 1.93 0.53 0.16
with 70% diameter stenosis, and a remote territory is subtended by
n stenotic and remote territory values. †Significance of the differencents DAll P
lue
02
5
2nd Wtient
CA
Rem
1.
1.
0.
1.
1.
1.
1.
1.
artery
betweeote territories in patients with CAD.
reserve; PET  positron emission tomography.
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Comparison of CMR and PET Perfusion Imaging October 16, 2012:1546–55Corresponding CV for inter-observer reproducibility were
17%, 13%, and 18%, respectively. The CMR intraobserver CV
were 9%, 14%, and 20%, respectively, and interobserver CV
were 16%, 18%, and 22%, respectively.
Diagnosis of CAD. VISUAL ANALYSIS. Sensitivity and
specificity against QCA were: PET 92% (95% confidence
interval [CI]: 72% to 99%) and 69% (95% CI: 41% to 88%);
CMR 86% (95% CI: 64% to 96%) and 76% (95% CI: 50%
to 92%). The CMR and PET sensitivity and specificity were
not significantly different (p  0.65 and 0.71, respectively).
he AUC were: PET 0.81 (95% CI: 0.66 to 0.96); CMR
.81 (95% CI: 0.65 to 0.96). If only those patients with
uantitative data suitable for analysis were considered,
ensitivity and specificity changed to 94% (95% CI: 71% to
A
B
Figure 1 Scatter Plots Comparing CMR- and
PET-Derived MPR
Scatter plots with fit lines comparing myocardial perfusion reserve (MPR) val-
ues from cardiac magnetic resonance (MPRCMR) and positron emission tomog-
raphy (MPRPET) for the entire myocardial territory (A) and the mean of the
lowest 2 segments in each territory (MPR2) (B).9%) and 67% (95% CI: 39% to 87%), and 85% (95% CI:1% to 96%) and 79% (95% CI: 49% to 94%) for PET and
MR, respectively.
QUANTITATIVE ANALYSIS. The AUC for MPR2PET to
detect significant CAD was 0.83 (95% CI: 0.73 to 0.94) and
for MPR2CMR was 0.83 (95% CI: 0.74 to 0.92) (p  0.96).
ensitivity and specificity against QCA were: MPR2PET
1.44: 82% and 87%; and MPRCMR 1.45: 82% and 81%
Fig. 4). The AUC was not significantly different from AUC
or visual analysis (p 0.73 and p 0.79 for PET and CMR,
espectively). An example case is shown in Figure 5.
The AUC was 0.85 (95% CI: 0.75 to 0.95) for MPR2PET
and MPR2CMR combined. There was no significant differ-
nce between AUC when MPR2PET and MPR2CMR were
both included in the model and when MPR2PET (p 
.406) or MPR2CMR (p  0.4749) alone were used.
The MPR2PET and MPR2CMR were inversely related to
he severity of CAD by QCA. For QCA subgroups 30%,
0% to 49%, 50% to 69%, 70% to 95%, and 95%
PR2PET and MPR2CMR were 1.93  0.39 and 1.89 
.46, 1.73  0.33 and 1.86  0.67, 1.58  0.4 and 1.54 
.47, 1.49  0.33 and 1.28  0.42, and 1.18  0.20 and
.26  0.22, respectively.
The AUC for absolute perfusion values during stress to
etect significant CAD were: PET 0.69 (95% CI: 0.56 to
.81) and CMR 0.72 (95% CI: 0.61 to 0.83). This was
ignificantly lower than MPR2 AUC with PET (p 0.049)
ut not CMR (p  0.12). Optimal absolute stress perfusion
utoffs were: PET 1.48 ml/min/g (sensitivity 80%, spec-
ficity 53%); and CMR 1.50 ml/min/g (sensitivity 63%,
pecificity 76%).
iscussion
e have demonstrated that, in patients with known or
uspected CAD, there is good correlation between MPRPET
and MPRCMR. The MPR2CMR also seems to have a similar
0.5 1.0 1.5 2.0 2.5 3.0 3.5
-2
-1
0
1
2
Figure 2 Agreement Between CMR and PET MPR
Bland-Altman plot showing the agreement between CMR- and PET-derived abso-
lute MPR measurements. Abbreviations as in Figure 1.
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ignificant coronary artery stenoses. However, the correlation
etween the absolute perfusion values from PET and CMR is
elatively weak.
To our knowledge, there are no previously published studies
omparing quantitative CMR myocardial perfusion with PET
n patients. Previous studies have been limited to semi quan-
itative analysis methods (18,19) or have involved healthy
olunteers (11–13). Semi-quantitative analysis has been shown
o be useful (20) and to correlate well with MPRPET in patents
with CAD (18,19). However, unlike fully quantitative analysis,
these methods only provide an index of perfusion reserve and
not a true MPR and might substantially underestimate perfu-
sion, particularly at higher perfusion values (19).
Studies using fully quantitative CMR methods are lim-
ited to small numbers of healthy volunteers. The results of
these studies are inconsistent and difficult to compare,
because each study employed different PET and CMR
A
C
Figure 3 Correlation and Agreement Between CMR- and PET-D
Scatter plots illustrating the correlation between absolute measures of myocardial
Altman plots (B and D, respectively) with limits of agreement lines (2 SDs). CMR methods. Pärkkä et al. (12) studied 18 healthy volunteerswith 15O-water PET and CMR. They used compartmental
modeling and found that MPR and stress perfusion values
were significantly correlated (r  0.48 and r  0.7,
respectively). However, rest perfusion values were not sig-
nificantly correlated. Fritz-Hansen et al. (11) studied 10
healthy volunteers with 13N-ammonia PET with the same
MR quantification method. They demonstrated, similar
o our findings, a significant correlation between global
PRPET and MPRCMR (r  0.7). They found an even
stronger correlation for the change in myocardial perfusion
between rest and stress (r  0.96). Both of these studies
found a tendency for CMR to underestimate MPR com-
pared with PET. In a smaller study of 5 volunteers, Pack et
al. (13) found that 3-T CMR and 13N-ammonia PET
perfusion and MPR values are well correlated but that MPR
might be in better agreement.
Both PET and CMR perfusion and MPR values in our
study are physiologically plausible and in the same range as
Absolute Perfusion Values
sion at rest (A) and during peak stress (C), along with the corresponding Bland-
iac magnetic resonance; PET  positron emission tomography.B
D
erived
perfu
cardin some previous studies (11,21–25) but lower than those
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Comparison of CMR and PET Perfusion Imaging October 16, 2012:1546–55reported by others (26). Patients are known to have lower
stress and rest perfusion than normal volunteers even in
remote territories (22,23). The mean difference between
PET and CMR perfusion values is small; however, the
limits of agreement are broad, particularly at higher stress
perfusion values. The findings that MPR, a ratio of stress
and rest perfusion values, correlates well but that the
absolute perfusion values correlate relatively poorly suggests
that the errors in quantification had a similar influence on
both rest and stress perfusion values and were subsequently
cancelled by the calculation of MPR. These errors might be
a result of either methodological or physiological factors.
Methodological considerations. Differences in voxel size
and acquisition methods (3-dimensional segments were
acquired with PET and 10-mm slices through the 16
segments with CMR) and the use of different post-
processing methods mean that, despite the calculation of
mean values in standard segments and territories, there is
likely to have been a small degree of misregistration between
the modalities. Furthermore, although partial volume effects
are corrected for with compartmental PET analysis (16),
these were not taken into account with CMR.
Positron emission tomography and CMR have both been
validated against gold-standard techniques; however, both
still have limitations. The PET studies have used different
tracers (e.g., 13N-ammonia vs. 15O water), acquisition
protocols, and analysis methods (e.g., Patlak, compartmen-
tal). In the present study, the method might underestimate
absolute perfusion (27)—an effect that would also be can-
celled by the calculation of MPR.
Quantitative CMR perfusion studies have used different
Figure 4 Diagnosis of Significant CAD on Angiography With Qu
Mean myocardial perfusion reserve (MPR) of the lowest 2 segments (MPR2) in rem
detection of coronary artery disease (CAD) (MPRCMR 1.45 and MPRPET 1.44) are smagnetic field strengths, contrast agents, perfusion se-quences, and post-processing algorithms. One of the main
challenges faced by CMR quantification is that, at higher
concentrations of contrast agent, there is a loss of linearity
between contrast agent concentration and signal intensity. It
is possible that these signal saturation effects influenced our
CMR results. However, we used a dual bolus method to
preserve signal linearity in the left ventricular blood pool
and allow calculation of the arterial input function. In
addition, a previous study has demonstrated that myocardial
signal intensity continues to increase at much higher doses
of contrast agent (up to at least 0.15 mmol/kg) than those
used here (28), although this study was in normal hearts
imaged with a hybrid echo planar pulse sequence. Further-
more, a 14-min interval between stress and rest imaging is
insufficient for complete dissipation of the contrast agent.
We used a published method (29) of baseline correction to
account for this; however, this might also have introduced
some error into rest perfusion measurements. We did not find,
in contrast to the previous volunteer studies, any evidence of
systematic errors for low or high values, indicating that CMR
is valid for a wide range of perfusion values.
It is also possible that systematic errors could relate to
the fact that PET (30,31) and particularly CMR (32)
have only moderate inter-study reproducibility. Regional
measurements of perfusion in particular tend to be less
reproducible than global measurements. Because the
reproducibility of data analysis was relatively high, this
might also be partly explained by physiological variation
of perfusion.
Physiological considerations. There are also likely to have
been real changes in perfusion, even though the interval
tive CMR- and PET-Derived MPR
70%) and stenotic (70%) territories. The best cutoff values for the
CMR  cardiac magnetic resonance; PET  positron emission tomography.antita
ote (
hown.between the PET and CMR scans was short. Little is
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changes in hydration affect myocardial perfusion. It is also
possible that such differences are more pronounced in
patients than in volunteers—for example, as a result of the
use of medications that affect perfusion.
Clinical implications. The novel finding that MPRCMR
correlates strongly with MPRPET is important, given the
proven utility of MPRPET. The MPRPET correlates in-
ersely with the degree of coronary artery stenosis at
ngiography (33). Furthermore, recent studies have dem-
nstrated that MPRPET is an independent predictor of
Figure 5 Case Example
Positron emission tomography (PET) (top), cardiac magnetic resonance (CMR)
(middle), and the x-ray angiogram of the left coronary artery of a 54-year-old
patient with diabetes and exertional angina. Basal, mid, and apical slices have
been taken from the PET study, which approximately correspond to the CMR
slices. There is a stress-induced perfusion defect in the infero-lateral region from
base to apex visible on both PET and CMR images. There is a corresponding
severe (95%) stenosis of the proximal circumflex artery. There was no other sig-
nificant angiographic disease. Myocardial perfusion reserve of the lowest 2 seg-
ments (MPR2) for each territory are shown in the table. The MPR2 for the
circumflex artery (CX) is below the cutoff of 1.44 and 1.45 for both PET and CMR,
respectively. LAD  left anterior descending artery; RCA  right coronary artery.utcome and predicts major adverse cardiac events andardiac death (3) in patients with suspected impaired
erfusion and reduced survival in patients with left ventric-
lar impairment (4).
In this study, we identified MPR2CMR and MPR2PET
cutoff values that detected CAD with a high sensitivity and
specificity. The MPR was superior to absolute stress perfu-
sion values for this purpose. The MPR2PET AUC was
significantly higher than absolute stress perfusion values
AUC, and there was also a trend toward significance with
MPR2CMR. This was reflected by optimal cutoff values for
absolute stress perfusion values that would be clinically less
useful due to modest sensitivity (CMR) or specificity
(PET). This is in contrast to some limited recent PET data
suggesting that a single absolute stress perfusion cutoff value
might be superior to MPR for the detection of CAD (21).
In addition, there does not seem to be any incremental value
in combining MPR data from both PET and CMR for the
diagnosis of CAD.
Quantification of images in general results in more
precise, reproducible, and user-independent results. Al-
though in this study there was no incremental benefit over
visual analysis, noninvasive quantification of perfusion
might be particularly useful in cases where visual assessment
is difficult, such as multivessel disease, severe left ventricular
impairment, and after coronary artery bypass grafting.
Moreover, it might eventually allow the definition of
thresholds of perfusion associated with myocardial ischemia
(34) and viability, both of which are known to be important
for selecting patients for revascularization procedures. This
study reinforces the evidence that quantitative CMR perfu-
sion data can be useful for the assessment of patients with
CAD, and at present, we can accurately differentiate normal
from abnormal myocardial territories. However, further
method refinement is required before the benefits can be
fully realized.
Study limitations. The sample size in this study is modest.
However, this is the first study in patients and larger than
previous volunteer studies. Furthermore, this limitation
applies more to the secondary objective of exploring diag-
nostic accuracy than to the primary aim of comparing
quantitative perfusion. Large sample sizes will be required
to demonstrate any significant differences in diagnostic
accuracy. We compared functional tests against an anatomic
reference standard (QCA), despite the well-documented
limitations of this approach. It might be better to use
fractional flow reserve as a reference standard in future
studies. However, x-ray coronary angiography is widely used
as the reference standard in both studies and in clinical
practice, and again, this does not affect the comparisons
made between PET and CMR, which was the main goal of
our study.
The patients included in this study had overall good left
ventricular function, and it is not clear how well these
methods translate into patients with left ventricular systolic
dysfunction (35). Finally, the relatively high prevalence of
CAD and the exclusion of segments in which image quality
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are likely to represent best possible results with currently
available quantitative techniques.
Conclusions
There is a strong correlation between MPR derived from
quantitative CMR and PET data, which is important given
the proven value of MPRPET for detection of CAD,
rognostication, and assessment of the microcirculation.
he MPRPET and MPRCMR seem to predict significant
AD equally well and accurately. However, in patients, the
bsolute perfusion values from PET and CMR are only
eakly correlated, suggesting that further refinement of
uantitative techniques is required.
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